Eyeliss™ from Sederma! Unsightly bags under the eyes are one of the visible signs of aging. Refresh and restore the youthful appearance of eyes with EYELISS™, a new patented ingredient from SEDERMA. Based on advanced peptide technology, EYELISS™ dramatically reduces the appearance of chronic bags under the eyes.
Various studies show that EYELISS™ targets the main causes that contribute to the formation of bags or puffiness under the eyes. Clinical Evaluation: Eyeliss™ contains a mixture of hesperidine methyl chalcone, the dipeptide Valyl-Tryptophane (VW) and the lipopeptide Pal-GQPR (one of the peptides in Matrixyl 3000). -PAL QQPR Content: 0.030% Recommended Usage: 3% Physical Form: Clear light brown liquid Solubility: Soluble in water. Long Term Storage: Recommended at 39.2° - 44.6° (4°-7°C) INCI Name:Water (and) Glycerin (and) Hesperidin Methyl Chalcone (and) Steareth-20 (and) Dipeptide-2 (and) Palmitoyl Tetrapeptide-7 *Eyeless™ is a trademark of Sederma, Inc.
-Prevents leakage of fluids by reducing capillary permeability
-Eliminates excess fluids to relieve the puffiness of surrounding tissue
-Enhances firmness to reduce slackening of the skin
-Minimizes inflammation to prevent tissue damage
-Topometry studies of chronic bags show that the height of the bag is significantly reduced after treatment with EYELISS™.
-65% of the panelists showed a measurable improvement after only 28 days!
-70% of the panelists showed a measurable improvement after 56 days!
-VAL TRP OH Content: 0.10%
-Hesperidin Content: 5.6%
When stored accordingly, raw material stable for 24 months.
MSDS and TDS